Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

What is “Good Distribution Practice” (GDP)? What does it mean for pharmaceutical licence holders?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q9 · Category A: Pharmacy licensing system and regulatory foundations (Q1-Q50)
Good Distribution Practice (GDP) is a set of quality management standards for the wholesale and distribution of medicines. It aims to ensure that the quality and integrity of medicines are maintained throughout the supply chain, from the manufacturer to the final retail outlet. GDP covers every aspect of medicine distribution, including establishing a quality management system; personnel qualifications and training; premises and equipment requirements, particularly storage conditions such as temperature and humidity control; order processing; receipt; storage; picking; dispatch; handling returns; and monitoring transport. For holders of a “wholesale dealer licence” in Hong Kong, compliance with GDP is not optional but a mandatory legal requirement. The Drug Office, Department of Health, conducts regular inspections of licensed wholesalers against GDP standards. Any serious GDP breach may result in the licence being suspended or revoked. GDP is therefore the fundamental operating standard for every wholesale medicines business.

📘 Regulatory basis

The Drug Office, Department of Health’s Good Distribution Practice for Pharmaceutical Products guideline is the main regulatory reference. It sets out in detail the standards and requirements that wholesalers must meet.

📗 Drew Tang's recommendations

Do not regard GDP as merely a pile of paperwork. It is a scientific management system. Effective implementation of GDP not only ensures compliance but can also improve operational efficiency, reduce errors, safeguard medicine quality and build customer confidence. We recommend that clients incorporate GDP requirements from the outset, beginning with warehouse selection and system development.

📕 Risk notice

The most common GDP oversights are incomplete temperature monitoring records, disorganised storage areas, and improper handling of returned and recalled pharmaceutical products. These details may seem minor, but any one of them could be treated as a major breach during an inspection by the Department of Health.

Back to Category A: Licence System and Regulatory Basics (Q1-Q50) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗